*Review* **Involvement of Tricarboxylic Acid Cycle Metabolites in Kidney Diseases**

**Alexis Paulina Jiménez-Uribe \*, Estefani Yaquelin Hernández-Cruz, Karla Jaqueline Ramírez-Magaña and José Pedraza-Chaverri**

> Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico; estefani.hernandez@quimica.unam.mx (E.Y.H.-C.); karlaa\_jaquelinee@comunidad.unam.mx (K.J.R.-M.); pedraza@unam.mx (J.P.-C.) **\*** Correspondence: jimenez.uribe.ap@comunidad.unam.mx

**Abstract:** Mitochondria are complex organelles that orchestrate several functions in the cell. The primary function recognized is energy production; however, other functions involve the communication with the rest of the cell through reactive oxygen species (ROS), calcium influx, mitochondrial DNA (mtDNA), adenosine triphosphate (ATP) levels, cytochrome c release, and also through tricarboxylic acid (TCA) metabolites. Kidney function highly depends on mitochondria; hence mitochondrial dysfunction is associated with kidney diseases. In addition to oxidative phosphorylation impairment, other mitochondrial abnormalities have been described in kidney diseases, such as induction of mitophagy, intrinsic pathway of apoptosis, and releasing molecules to communicate to the rest of the cell. The TCA cycle is a metabolic pathway whose primary function is to generate electrons to feed the electron transport system (ETS) to drives energy production. However, TCA cycle metabolites can also release from mitochondria or produced in the cytosol to exert different functions and modify cell behavior. Here we review the involvement of some of the functions of TCA metabolites in kidney diseases.

**Keywords:** mitochondria; TCA cycle metabolites; kidney diseases
